273 related articles for article (PubMed ID: 21262861)
1. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer.
Aza-Carmona M; Shears DJ; Yuste-Checa P; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Benito-Sanz S; Rodríguez JI; Argente J; Campos-Barros A; Scambler PJ; Heath KE
Hum Mol Genet; 2011 Apr; 20(8):1547-59. PubMed ID: 21262861
[TBL] [Abstract][Full Text] [Related]
2. NPPB and ACAN, two novel SHOX2 transcription targets implicated in skeletal development.
Aza-Carmona M; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Gorbenko-del Blanco D; Rodriguez JI; Benito-Sanz S; Campos-Barros A; Heath KE
PLoS One; 2014; 9(1):e83104. PubMed ID: 24421874
[TBL] [Abstract][Full Text] [Related]
3. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 is a target of the homeobox transcription factor SHOX in limb development.
Decker E; Durand C; Bender S; Rödelsperger C; Glaser A; Hecht J; Schneider KU; Rappold G
Hum Mol Genet; 2011 Apr; 20(8):1524-35. PubMed ID: 21273290
[TBL] [Abstract][Full Text] [Related]
5. Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis.
Schneider KU; Marchini A; Sabherwal N; Röth R; Niesler B; Marttila T; Blaschke RJ; Lawson M; Dumic M; Rappold G
Hum Mutat; 2005 Jul; 26(1):44-52. PubMed ID: 15931687
[TBL] [Abstract][Full Text] [Related]
6. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
[TBL] [Abstract][Full Text] [Related]
7. The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis.
Liu CF; Lefebvre V
Nucleic Acids Res; 2015 Sep; 43(17):8183-203. PubMed ID: 26150426
[TBL] [Abstract][Full Text] [Related]
8. Short stature caused by isolated SHOX gene haploinsufficiency: update on the diagnosis and treatment.
Jorge AA; Funari MF; Nishi MY; Mendonca BB
Pediatr Endocrinol Rev; 2010 Dec; 8(2):79-85. PubMed ID: 21150837
[TBL] [Abstract][Full Text] [Related]
9. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis.
Hirschfeldova K; Solc R; Baxova A; Zapletalova J; Kebrdlova V; Gaillyova R; Prasilova S; Soukalova J; Mihalova R; Lnenicka P; Florianova M; Stekrova J
Gene; 2012 Jan; 491(2):123-7. PubMed ID: 22020182
[TBL] [Abstract][Full Text] [Related]
10. Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome.
Sabherwal N; Schneider KU; Blaschke RJ; Marchini A; Rappold G
J Cell Sci; 2004 Jun; 117(Pt 14):3041-8. PubMed ID: 15173321
[TBL] [Abstract][Full Text] [Related]
11. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands.
Benito-Sanz S; del Blanco DG; Aza-Carmona M; Magano LF; Lapunzina P; Argente J; Campos-Barros A; Heath KE
Hum Mutat; 2006 Oct; 27(10):1062. PubMed ID: 16941489
[TBL] [Abstract][Full Text] [Related]
12. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
Han Y; Lefebvre V
Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis.
Rodríguez FA; Unanue N; Hernandez MI; Basaure J; Heath KE; Cassorla F
J Pediatr Endocrinol Metab; 2013; 26(7-8):729-34. PubMed ID: 23729538
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).
Benito-Sanz S; Barroso E; Heine-Suñer D; Hisado-Oliva A; Romanelli V; Rosell J; Aragones A; Caimari M; Argente J; Ross JL; Zinn AR; Gracia R; Lapunzina P; Campos-Barros A; Heath KE
J Clin Endocrinol Metab; 2011 Feb; 96(2):E404-12. PubMed ID: 21147883
[TBL] [Abstract][Full Text] [Related]
15. Different approaches in the molecular analysis of the SHOX gene dysfunctions.
Stuppia L; Gatta V; Antonucci I; Giuliani R; Palka G
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):30-3. PubMed ID: 21057183
[TBL] [Abstract][Full Text] [Related]
16. The SHOX region and its mutations.
Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
[TBL] [Abstract][Full Text] [Related]
17. Complete SHOX deficiency causes Langer mesomelic dysplasia.
Zinn AR; Wei F; Zhang L; Elder FF; Scott CI; Marttila P; Ross JL
Am J Med Genet; 2002 Jun; 110(2):158-63. PubMed ID: 12116254
[TBL] [Abstract][Full Text] [Related]
18. BNP is a transcriptional target of the short stature homeobox gene SHOX.
Marchini A; Häcker B; Marttila T; Hesse V; Emons J; Weiss B; Karperien M; Rappold G
Hum Mol Genet; 2007 Dec; 16(24):3081-7. PubMed ID: 17881654
[TBL] [Abstract][Full Text] [Related]
19. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene.
Lefebvre V; Li P; de Crombrugghe B
EMBO J; 1998 Oct; 17(19):5718-33. PubMed ID: 9755172
[TBL] [Abstract][Full Text] [Related]
20. Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis.
Szénási T; Kénesi E; Nagy A; Molnár A; Bálint BL; Zvara Á; Csabai Z; Deák F; Boros Oláh B; Mátés L; Nagy L; Puskás LG; Kiss I
Biochim Biophys Acta; 2013 Oct; 1829(10):1075-91. PubMed ID: 23860260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
